Our center thrives on collaborative partnerships with other research institutions, healthcare organizations, and industry leaders. These relationships enhance our research capabilities and accelerate the translation of laboratory findings into therapeutic interventions. Partnerships with local and national Alzheimer's disease networks broaden the impact of our research and clinical trials.

This section showcases the diverse sources of support and funding that enable the USC ADRC to remain at the forefront of ADRD research, reflecting the broad community and institutional commitment to combating Alzheimer's disease.

As one of the initial Alzheimer's Disease Research Centers recognized by the National Institute on Aging (NIA) since 1984, USC ADRC continues to receive substantial federal funding. These grants support a wide range of projects, from basic genetic research to clinical trials and advanced imaging studies, aiming to uncover the mechanisms of Alzheimer's disease and develop effective therapies. A key grant supporting our center is the NIA grant 5P30AG066530-05, which provides critical funding for our ongoing research and operational needs. More information about this grant can be found here.

The USC ADRC benefits from robust backing by the university’s leadership, including the President, the Vice President for Research, and the Senior Vice President for Health Sciences. This strong institutional support underscores the university’s commitment to addressing critical challenges in Alzheimer's disease and related disorders (ADRD) research.